1-triazole ribose derivative as well as preparation method and application thereof
By using 1-triazole ribose derivatives as targeting molecules to couple ribose, efficient delivery and stability of iRNA are achieved, and the problem of insufficient nucleic acid delivery efficiency and stability in the prior art is solved, and the efficacy and delivery efficiency are improved.
CN119930717APending Publication Date: 2025-05-06PHARMA SHANGHAI
0 Cites 0 Cited by
Patent Information
- Application Number
- CN202311445856.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-02
- Publication Date
- 2025-05-06
Smart Images

Figure CN119930717A_ABST
Abstract
The invention provides a 1-triazole ribose derivative as well as a preparation method and application thereof. The invention relates to a 1-triazole ribose derivative, which is characterized in that the 1-triazole ribose derivative is a targeting molecule coupling ribose and is selected from compounds with a structure as shown in a formula (I), DMT represents 4, 4 '-dimethoxytriphenylmethyl, DMT represents 4, 4'-dimethoxytriphenylmethyl, DMT represents 4, 4 '-dimethoxytriphenylmethyl, and DMT represents 4, 4'-dimethoxytriphenylmethyl. R represents-L-R1; l represents a C1-C25 hydrocarbon chain which can be substituted by one or more groups, the one or more groups are the same or different, and R1 represents a compound 1-GalNAc. The 1-triazole ribose derivative with the structure as shown in the formula (I) has strong stability on nucleic acid clastic enzyme in a cell environment, the action time of small nucleic acid molecules in cells is greatly prolonged, and the small nucleic acid molecules can greatly reduce the dosage and improve the drug effect clinically. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art
